✦ LIBER ✦

Clinical Potential of RANKL Inhibition for the Management of Postmenopausal Osteoporosis and Other Metabolic Bone Diseases

✍ Scribed by Delmas, Pierre D.

Book ID: 123188715
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 685 KB
Volume: 11
Category: Article
ISSN: 1094-6950
DOI: 10.1016/j.jocd.2008.02.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An antibody against RANKL for the treatm

An antibody against RANKL for the treatment of osteoporosis, inflammatory and malignant bone diseases

✍ Eduardo Maldonado-Gonzales; Peter Pietschmann 📂 Article 📅 2010 🏛 Springer Vienna 🌐 German ⚖ 158 KB

Biochemical markers of bone turnover: po

Biochemical markers of bone turnover: potential use in the investigation and management of postmenopausal osteoporosis

✍ P. Szulc; P. D. Delmas 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 450 KB

Clinical Implications of the Osteoproteg

Clinical Implications of the Osteoprotegerin/RANKL/RANK System for Bone and Vascular Diseases

✍ Hofbauer, Lorenz C. 📂 Article 📅 2004 🏛 American Medical Association 🌐 English ⚖ 162 KB

Testing for vitamin D and other trends i

Testing for vitamin D and other trends in the clinical management of osteoporosis

✍ Rowell, David; Gordon, Louisa 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 205 KB

Fluoride treatment of postmenopausal ost

Fluoride treatment of postmenopausal osteoporosis: Age, renal function, and other clinical factors in the osteogenic response

✍ DR. T. M. Murray; J. E. Harrison; T. A. Bayley; R. G. Josse; W. C. Sturtridge; R 📂 Article 📅 2010 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 718 KB

Biochemical Markers of Bone Turnover in

Biochemical Markers of Bone Turnover in the Clinical Development of Drugs for Osteoporosis and Metastatic Bone Disease

✍ Serge Cremers, Dr Patrick Garnero 📂 Article 📅 2006 🏛 Springer International Publishing AG 🌐 English ⚖ 226 KB